cyclosporine has been researched along with Wiskott-Aldrich Syndrome in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Ahmed Nacer, R; Ait Ouali, D; Baazizi, M; Benakli, M; Bouarab, H; Hamladji, RM; Harieche, F; Mehdid, F; Rahmoune, N; Zerkout, S | 1 |
Benninghoff, U; Friedrich, W; Hönig, M; Schulz, A; Schütz, C | 1 |
Irshad, FA; Onciu, MM; Walton, RC; Wilson, TD | 1 |
Bureo, E; Diaz de Heredia, C; Gonzalez-Vicent, M; Maldonado, MS; Martinez, A; Muñoz, A; Olivé, T; Sastre, A | 1 |
Abrams, J; Meisels, IS; Roy-Chaudhury, P; Shapiro, ME; Strom, TB | 1 |
Abboud, C; Constine, L; DiPersio, J; Duerst, R; Liesveld, J; Linder, T; McKenna, B; Packman, C; Rapoport, A; Rowe, J; Silverman, W; Swift, S; Wedow, L; Zwetsch, L | 1 |
6 other study(ies) available for cyclosporine and Wiskott-Aldrich Syndrome
Article | Year |
---|---|
Successful Allogeneic Peripheral Blood Stem Cell Transplantation in 4 Wiskott-Aldrich Syndrome Patients.
Topics: Busulfan; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Wiskott-Aldrich Syndrome | 2022 |
Results and long-term outcome in 39 patients with Wiskott-Aldrich syndrome transplanted from HLA-matched and -mismatched donors.
Topics: Antiviral Agents; Child; Child, Preschool; Chimerism; Cidofovir; Cyclosporine; Cytosine; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Living Donors; Male; Organophosphonates; Treatment Failure; Wiskott-Aldrich Syndrome | 2009 |
Conjunctival posttransplantation lymphoproliferative disorder.
Topics: Biomarkers; Bone Marrow Transplantation; Child; Conjunctival Diseases; Cyclosporine; DNA, Viral; Epstein-Barr Virus Infections; Eye Infections, Viral; Humans; Immunoenzyme Techniques; In Situ Hybridization; Lymphoproliferative Disorders; Male; Prednisone; T-Lymphocytes, Cytotoxic; Wiskott-Aldrich Syndrome | 2007 |
Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Topics: Antilymphocyte Serum; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Haplotypes; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Living Donors; Lymphocyte Depletion; Male; Melphalan; Multiple Organ Failure; Postoperative Complications; Reoperation; Retrospective Studies; Spain; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Wiskott-Aldrich Syndrome | 2007 |
Renal allograft rejection in a patient with the Wiskott-Aldrich syndrome.
Topics: Adult; Azathioprine; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Methylprednisolone; Muromonab-CD3; Prednisone; Wiskott-Aldrich Syndrome | 1995 |
Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Calcium Channel Blockers; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Infant; Life Tables; Male; Methotrexate; Methylprednisolone; Middle Aged; Nifedipine; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Wiskott-Aldrich Syndrome | 1999 |